Harbour Investments Inc. boosted its position in Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR – Free Report) by 43.4% during the 3rd quarter, Holdings Channel reports. The fund owned 9,563 shares of the company’s stock after buying an additional 2,895 shares during the period. Harbour Investments Inc.’s holdings in Amplify Weight Loss Drug & Treatment ETF were worth $256,000 as of its most recent SEC filing.
Amplify Weight Loss Drug & Treatment ETF Trading Down 3.3 %
Shares of NYSEARCA:THNR opened at $23.15 on Monday. The stock’s 50 day moving average price is $26.22. Amplify Weight Loss Drug & Treatment ETF has a twelve month low of $23.11 and a twelve month high of $28.19.
Further Reading
- Five stocks we like better than Amplify Weight Loss Drug & Treatment ETF
- Differences Between Momentum Investing and Long Term Investing
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Insider Trading – What You Need to Know
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding THNR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR – Free Report).
Receive News & Ratings for Amplify Weight Loss Drug & Treatment ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amplify Weight Loss Drug & Treatment ETF and related companies with MarketBeat.com's FREE daily email newsletter.
